Vox Markets Logo
15th November 2023
07:00

Synairgen plc - Grant of Options

11th October 2023
06:00

Synairgen plc - Appointment of New Chief Financial Officer

3rd October 2023
06:00

Synairgen plc - Appointment of Chief Medical Officer

21st September 2023
06:00

Synairgen plc - Interim Results

29th June 2023
17:02

Synairgen plc - Result of AGM

29th June 2023
09:00

Synairgen plc - Annual General Meeting Presentation

22nd June 2023
06:00

Synairgen plc - Grant of Options

23rd May 2023
06:00

Synairgen plc - Posting of Annual Report and Notice of AGM

27th April 2023
06:00

Synairgen plc - 2022 Full Year Results

17th April 2023
06:00

Synairgen plc - Notice of Full Year results

23rd December 2022
11:30

Synairgen plc - SPRINTER Trial Results Published

1st December 2022
07:00

Synairgen plc - Board Changes

6th October 2022
12:35

Synairgen plc - Holding(s) in Company

Synairgen Plc (SNG.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    201.38M

Synairgen Plc Company Profile

Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.

The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic Key Opinion Leader network to discover and develop novel therapies for respiratory disease.

Watchlist